8061 Seika
- 3995
- +10+0.25%
Seika News
Kameda Seika Co Cuts FY Net View to Y2.20B
GROUP New Forecast Prior For Year To Mar 2024 Forecast Revenue Y95.50 bln Y97.50 bln Operating Profit Y4.40 bln
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○List of trading stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1515＞ Nittetsu Mining 5070 4765 ＜1663＞ K&O Energy 3270 2853 ＜1934＞ Yourtech 1480 1381 ＜1939＞ Yodenko 3920 3725 ＜1982＞ Hibiya Setsu 2965 2759 ＜2288＞
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1766＞ Token Corpo 10350 10740 ＜2153＞ eJay HD 1746 1833 ＜2301＞ academic information 1776 1857 ＜2325＞ NJS 3120 3250 ＜2413＞ M3
Seika Sangyo adopts sales support tool “DPS for Sales” (NTT DATA Intramart, Inc.)
2024/4/2 NTT DATA INTRAMART CORPORATION NTT DATA INTRAMART CORPORATION announced the following news release on 2024/4/2. 2024/4/2 Seika Sangyo Adopts the Sales Support Tool “DPS for Sales” - Significantly Improving Business Efficiency in Sales Administration by Making Various Information Paperless Related to Projects and Automatic Data Linkage with Core Systems - Inquiries about this matter
Global Super Absorbent Polymer Market Analysis Report 2024-2030, Featuring BASF, LG Chem, Formosa Plastics, SONGWON, Evonik, Kao, NIPPON Shokubai, Sumitomo Seika Chemicals and Yixing Danson Technology
Brands that moved the day before part 1 Seika Sangyo, Okuwa, Kose, etc.
<コード>Stock name closing price on the 27th ⇒ compared to the previous day Daiki Axis ＜4245＞ 746 +45 announced the acceptance of orders for large-scale overseas projects. Interac ＜7725＞ won large orders for 1287 +50 image sensor inspection-related products. It exceeded 100 billion yen in deposit assets, which is the target of the Traders ＜8704＞ 707 +11 medium-term management plan. SBI Leasing ＜5834＞ 3725 -125 stopped purchasing aircraft for sale announced on 3/15. Gloam HD ＜8938＞ 67
Backstage [stocks that moved, stocks that were made]
*Daiki Axis ＜4245＞ 746 +45 announced the acceptance of orders for large-scale overseas projects. *Interac ＜7725＞ won large orders for 1287 +50 image sensor inspection-related products. *Trader's ＜8704＞ 707 +11 medium-term management plan target surpassed 100 billion yen in deposit assets. *SBI Leasing ＜5834＞ 3725 -125 The purchase of aircraft for sale announced on 3/15 was discontinued. *Glome HD ＜8938＞ 679 +32 hospice housing
Seika and others continued to rank, and their earnings and dividend forecasts for the fiscal year ending March 24 were revised downward (revised)
The corrections will be made as follows. (Wrong) ItBookHD ＜1447＞ (positive) Seika ＜8061＞ Seika ＜8061＞ is ranked (as of 13:32). Massive backlash. An upward revision of earnings forecasts was announced the day before, and operating income for the fiscal year ending 24/3 was raised from the previous forecast of 4.5 billion yen to 5.3 billion yen, an increase of 14.3% from the previous fiscal year. The background is that additional construction and projects that are ahead of schedule have piled up, and that major domestic and international subsidiaries have earnings forecasts that exceed previous forecasts. The annual dividend is also 120 as previously forecast
Hokuriku Electric Power, 24/3 revised upward operating profit 100 billion yen ← 75 billion yen
Hokuriku Electric Power Company ＜9505＞ announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised upward from 75 billion yen to 100 billion yen. It reflected an improvement in terms of profit associated with an increase in the amount of electricity generated and received by hydroelectric power. Net profit is undecided because equipment restoration costs etc. due to the Noto Peninsula earthquake have not been determined. The previous forecast of sales falling 2% to 805 billion yen was left unchanged. [Positive Evaluation] ＜8061＞Seika Correction | ＜7485＞Okaya Koki Correction＜762
Seika Corp Raises FY Dividend Plan to Y150.00
Seika Corp. (8061.TO) PARENT Latest Revision Previous For Year to Mar 2024 Plan Year-end Y90.00 Y60.00 Annual Y150.00 Y120.00 T
Sumitomo Seika Chemicals Sees FY Net Y5.00B
Sumitomo Seika Chemicals Co. Ltd. also released the following forecasts: GROUP Year Ending Mar 2024 Revenue Y143.00 bln Operating Profit Y8.50 bln
Kameda Seika Co 9-Mos Net Y1.98B Vs Net Y1.60B
Kameda Seika Co. Ltd. (2220.TO) Japan Nine Months Ended December 31 GROUP 2023 2022 Revenue Y70.14 bln Y71.84 bln Operating Profit Y2.90 bln Y
Seika Corp Sees FY Net Y3.40B
Seika Corp. also released the following forecasts: GROUP Year Ending Mar 2024 Revenue Y85.00 bln Operating Profit Y4.50 bln Pretax Profit
Sumitomo Seika Chemicals 1H Net Y3.07B Vs Net Y5.92B
Sumitomo Seika Chemicals Co. Ltd. (4008.TO) Japan 1st Half Ended September 30 GROUP 2023 2022 Revenue Y69.66 bln Y73.44 bln Operating Profit Y3.78
Kameda Seika Co 1H Net Y980.00M Vs Net Y1.87B
Kameda Seika Co. Ltd. (2220.TO) Japan 1st Half Ended September 30 GROUP 2023 2022 Revenue Y44.07 bln Y46.02 bln Operating Profit Y854.00 mln
Meiji Seika Pharma Presents Positive Findings From Phase II Study of ME3183, Novel Highly-Potent Selective PDE4 Inhibitor, in Patients With Plaque Psoriasis at EADV Congress 2023
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Daikichiro Kobayashi) today announced that positive findings from the phase II clinical trial of ME3183, a novel highly-potent
Seika Corp Sees 1H Parent Pretax Y2.05B
PARENT New Forecast Prior For Year to Sep 2023 Forecast Revenue Y39.00 bln N/A Pretax Profit Y2.05 bln N/A Net Prof
Seika Corp Sees 1H Net Y1.00B
Seika Corp. also released the following forecasts: GROUP 1st Half To Sep 2023 Revenue Y42.50 bln Operating Profit Y1.40 bln Pretax Profit
Meiji Seika Pharma Announces Positive Results in Phase II Study of ME3183, a Novel Highly-Potent Selective PDE4 Inhibitor, in Patients With Moderate-to-Severe Plaque Psoriasis in the United States and Canada
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Daikichiro Kobayashi) today announced that ME3183, a novel highly-potent selective phosphodiesterase-4 (PDE4) inhibitor, met the
Sumitomo Seika Chemicals 1Q Net Y727.00M Vs Net Y2.50B
Sumitomo Seika Chemicals Co. Ltd. (4008.TO) Japan 1st Quarter Ended June 30 GROUP 2023 2022 Revenue Y34.10 bln Y36.95 bln Operating Profit Y1.10
Analysis
Price Target
No Data
